[HTML][HTML] Discovery and development of safe-in-man broad-spectrum antiviral agents

PI Andersen, A Ianevski, H Lysvand… - International Journal of …, 2020 - Elsevier
Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-
specific vaccines and antiviral drugs are the most powerful tools to combat viral diseases …

Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action

H Yousefi, L Mashouri, SC Okpechi, N Alahari… - Biochemical …, 2021 - Elsevier
The outbreak of a novel coronavirus (SARS-CoV-2) has caused a major public health
concern across the globe. SARS-CoV-2 is the seventh coronavirus that is known to cause …

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

KT Choy, AYL Wong, P Kaewpreedee, SF Sia, D Chen… - Antiviral research, 2020 - Elsevier
Highlights•Remdesivir inhibits SARS-CoV-2 replication in Vero-E6 cells with EC 50 at 23.15
μM.•Lopinavir but not ritonavir inhibits SARS-CoV-2 replication with EC 50 at 26.63 μM.• …

[HTML][HTML] A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

JP Changeux, Z Amoura… - Comptes …, 2020 - comptes-rendus.academie-sciences …
SARS-CoV-2 epidemics raises a considerable issue of public health at the planetary scale.
There is a pressing urgency to find treatments based upon currently available scientific …

High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses

L Shen, J Niu, C Wang, B Huang, W Wang… - Journal of …, 2019 - Am Soc Microbiol
Coronaviruses (CoVs) act as cross-species viruses and have the potential to spread rapidly
into new host species and cause epidemic diseases. Despite the severe public health threat …

Potential antiviral options against SARS-CoV-2 infection

A Ianevski, R Yao, MH Fenstad, S Biza, E Zusinaite… - Viruses, 2020 - mdpi.com
As of June 2020, the number of people infected with severe acute respiratory coronavirus 2
(SARS-CoV-2) continues to skyrocket, with more than 6.7 million cases worldwide. Both the …

SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury

M Fenrich, S Mrdenovic, M Balog, S Tomic… - Frontiers in cellular …, 2020 - frontiersin.org
Coronavirus disease (CoVID-19), caused by recently identified severe acute respiratory
distress syndrome coronavirus 2 (SARS-CoV-2), is characterized by inconsistent clinical …

Alkaloids as potential antivirals. A comprehensive review

S Faisal, SL Badshah, B Kubra, AH Emwas… - Natural Products and …, 2023 - Springer
Alkaloids are a diverse group of natural phytochemicals. These phytochemicals in plants
provide them protection against pests, and herbivorous organisms and also control their …

Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E

R Kumar, M Afsar, N Khandelwal, Y Chander, T Riyesh… - Antiviral research, 2021 - Elsevier
Emetine is a FDA-approved drug for the treatment of amebiasis. Previously we
demonstrated the antiviral efficacy of emetine against some RNA and DNA viruses. In this …

Different aspects of emetine's capabilities as a highly potent SARS-CoV-2 inhibitor against COVID-19

M Valipour - ACS Pharmacology & Translational Science, 2022 - ACS Publications
In the global movement to find the appropriate agents to fight the coronavirus disease of
2019 (COVID-19), emetine is one of the strongest anti-SARS-CoV-2 compounds with sub …